Xtant Medical Reports Strong Q1 Growth Amid Shareholding Changes Xtant Medical Holdings, Inc. shares insights into a secondary stock sale by OrbiMed and previews significant revenue growth for Q1 2025, citing an increase of up to 19%.

Xtant Medical Reports Strong Q1 Growth Amid Shareholding Changes #USA #Belgrade #Xtant_Medical #OrbiMed_Advisors #Nantahala_Capital